Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 236 of 236 entries
Sorted by: Best Match Show Resources per page
Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review.

Frontiers in nutrition

Wheatley SD, Deakin TA, Arjomandkhah NC, Hollinrake PB, Reeves TE.
PMID: 34336909
Front Nutr. 2021 Jul 15;8:687658. doi: 10.3389/fnut.2021.687658. eCollection 2021.

Although carbohydrate restriction is not a new approach for the management of Type 2 diabetes, interest in its safety and efficacy has increased significantly in recent years. The purpose of the current narrative review is to summarise the key...

Cite
Wheatley SD, Deakin TA, Arjomandkhah NC, et al. Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review. Front Nutr. 2021;8:687658doi: 10.3389/fnut.2021.687658.
Wheatley, S. D., Deakin, T. A., Arjomandkhah, N. C., Hollinrake, P. B., & Reeves, T. E. (2021). Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review. Frontiers in nutrition, 8687658. https://doi.org/10.3389/fnut.2021.687658
Wheatley, Sean D, et al. "Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review." Frontiers in nutrition vol. 8 (2021): 687658. doi: https://doi.org/10.3389/fnut.2021.687658
Wheatley SD, Deakin TA, Arjomandkhah NC, Hollinrake PB, Reeves TE. Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes-A Narrative Review. Front Nutr. 2021 Jul 15;8:687658. doi: 10.3389/fnut.2021.687658. eCollection 2021. PMID: 34336909; PMCID: PMC8319397.
Copy Download .nbib Format: NLM
Intrinsic Aerobic Capacity Affects Hippocampal pAkt and HSP72 Response to an Acute High Fat Diet and Heat Treatment in Rats.

Journal of Alzheimer's disease reports

Gan L, Wan X, Ma D, Yang FC, Zhu J, Rogers RS, Wheatley JL, Koch LG, Britton SL, Thyfault JP, Geiger PC, Stanford JA.
PMID: 34368631
J Alzheimers Dis Rep. 2021 Jun 08;5(1):469-475. doi: 10.3233/ADR-200289. eCollection 2021.

BACKGROUND: Aerobic capacity is associated with metabolic, cardiovascular, and neurological health. Low-capacity runner (LCR) rats display low aerobic capacity, metabolic dysfuction, and spatial memory deficits. A heat treatment (HT) can improve metabolic dysfunction in LCR peripheral organs after high...

Cite
Gan L, Wan X, Ma D, et al. Intrinsic Aerobic Capacity Affects Hippocampal pAkt and HSP72 Response to an Acute High Fat Diet and Heat Treatment in Rats. J Alzheimers Dis Rep. 2021;5(1):469-475doi: 10.3233/ADR-200289.
Gan, L., Wan, X., Ma, D., Yang, F. C., Zhu, J., Rogers, R. S., Wheatley, J. L., Koch, L. G., Britton, S. L., Thyfault, J. P., Geiger, P. C., & Stanford, J. A. (2021). Intrinsic Aerobic Capacity Affects Hippocampal pAkt and HSP72 Response to an Acute High Fat Diet and Heat Treatment in Rats. Journal of Alzheimer's disease reports, 5(1), 469-475. https://doi.org/10.3233/ADR-200289
Gan, Li, et al. "Intrinsic Aerobic Capacity Affects Hippocampal pAkt and HSP72 Response to an Acute High Fat Diet and Heat Treatment in Rats." Journal of Alzheimer's disease reports vol. 5,1 (2021): 469-475. doi: https://doi.org/10.3233/ADR-200289
Gan L, Wan X, Ma D, Yang FC, Zhu J, Rogers RS, Wheatley JL, Koch LG, Britton SL, Thyfault JP, Geiger PC, Stanford JA. Intrinsic Aerobic Capacity Affects Hippocampal pAkt and HSP72 Response to an Acute High Fat Diet and Heat Treatment in Rats. J Alzheimers Dis Rep. 2021 Jun 08;5(1):469-475. doi: 10.3233/ADR-200289. eCollection 2021. PMID: 34368631; PMCID: PMC8293662.
Copy Download .nbib Format: NLM
Current and future nanoparticle vaccines for COVID-19.

EBioMedicine

Vu MN, Kelly HG, Kent SJ, Wheatley AK.
PMID: 34801965
EBioMedicine. 2021 Nov 18;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 18.

COVID-19 has become a major cause of global mortality and driven massive health and economic disruptions. Mass global vaccination offers the most efficient pathway towards ending the pandemic. The development and deployment of first-generation COVID-19 vaccines, encompassing mRNA or...

Cite
Vu MN, Kelly HG, Kent SJ, et al. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021;74:103699doi: 10.1016/j.ebiom.2021.103699.
Vu, M. N., Kelly, H. G., Kent, S. J., & Wheatley, A. K. (2021). Current and future nanoparticle vaccines for COVID-19. EBioMedicine, 74103699. https://doi.org/10.1016/j.ebiom.2021.103699
Vu, Mai N, et al. "Current and future nanoparticle vaccines for COVID-19." EBioMedicine vol. 74 (2021): 103699. doi: https://doi.org/10.1016/j.ebiom.2021.103699
Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021 Nov 18;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 18. PMID: 34801965; PMCID: PMC8602808.
Copy Download .nbib Format: NLM
Current and future nanoparticle vaccines for COVID-19.

EBioMedicine

Vu MN, Kelly HG, Kent SJ, Wheatley AK.
PMID: 34801965
EBioMedicine. 2021 Nov 18;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 18.

COVID-19 has become a major cause of global mortality and driven massive health and economic disruptions. Mass global vaccination offers the most efficient pathway towards ending the pandemic. The development and deployment of first-generation COVID-19 vaccines, encompassing mRNA or...

Cite
Vu MN, Kelly HG, Kent SJ, et al. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021;74:103699doi: 10.1016/j.ebiom.2021.103699.
Vu, M. N., Kelly, H. G., Kent, S. J., & Wheatley, A. K. (2021). Current and future nanoparticle vaccines for COVID-19. EBioMedicine, 74103699. https://doi.org/10.1016/j.ebiom.2021.103699
Vu, Mai N, et al. "Current and future nanoparticle vaccines for COVID-19." EBioMedicine vol. 74 (2021): 103699. doi: https://doi.org/10.1016/j.ebiom.2021.103699
Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021 Nov 18;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 18. PMID: 34801965; PMCID: PMC8602808.
Copy Download .nbib Format: NLM
Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence.

Immunology and cell biology

Vanderven HA, Esterbauer R, Jegaskanda S, Tan HX, Wheatley AK, Kent SJ.
PMID: 34687553
Immunol Cell Biol. 2021 Oct 23; doi: 10.1111/imcb.12508. Epub 2021 Oct 23.

Humans are exposed to influenza virus through periodic infections. Due to these repeated exposures, human populations commonly have elevated antibody titers targeting the conserved internal influenza virus nucleoprotein (NP). Despite the presence of anti-NP antibodies, humans are acutely susceptible...

Cite
Vanderven HA, Esterbauer R, Jegaskanda S, et al. Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunol Cell Biol. 2021;doi: 10.1111/imcb.12508.
Vanderven, H. A., Esterbauer, R., Jegaskanda, S., Tan, H. X., Wheatley, A. K., & Kent, S. J. (2021). Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunology and cell biology, . https://doi.org/10.1111/imcb.12508
Vanderven, Hillary A, et al. "Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence." Immunology and cell biology vol. (2021). doi: https://doi.org/10.1111/imcb.12508
Vanderven HA, Esterbauer R, Jegaskanda S, Tan HX, Wheatley AK, Kent SJ. Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunol Cell Biol. 2021 Oct 23; doi: 10.1111/imcb.12508. Epub 2021 Oct 23. PMID: 34687553.
Copy Download .nbib Format: NLM
Current and future nanoparticle vaccines for COVID-19.

EBioMedicine

Vu MN, Kelly HG, Kent SJ, Wheatley AK.
PMID: 34801965
EBioMedicine. 2021 Nov 18;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 18.

COVID-19 has become a major cause of global mortality and driven massive health and economic disruptions. Mass global vaccination offers the most efficient pathway towards ending the pandemic. The development and deployment of first-generation COVID-19 vaccines, encompassing mRNA or...

Cite
Vu MN, Kelly HG, Kent SJ, et al. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021;74:103699doi: 10.1016/j.ebiom.2021.103699.
Vu, M. N., Kelly, H. G., Kent, S. J., & Wheatley, A. K. (2021). Current and future nanoparticle vaccines for COVID-19. EBioMedicine, 74103699. https://doi.org/10.1016/j.ebiom.2021.103699
Vu, Mai N, et al. "Current and future nanoparticle vaccines for COVID-19." EBioMedicine vol. 74 (2021): 103699. doi: https://doi.org/10.1016/j.ebiom.2021.103699
Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. EBioMedicine. 2021 Nov 18;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 18. PMID: 34801965; PMCID: PMC8602808.
Copy Download .nbib Format: NLM
Controlled Synthesis of Large Single Crystals of Metal-Organic Framework CPO-27-Ni Prepared by a Modulation Approach: In situ Single-Crystal X-ray Diffraction Studies.

Chemistry (Weinheim an der Bergstrasse, Germany)

Vornholt SM, Elliott CG, Rice CM, Russell SE, Kerr PJ, Rainer DN, Mazur M, Warren MR, Wheatley PS, Morris RE.
PMID: 33783895
Chemistry. 2021 Jun 10;27(33):8537-8546. doi: 10.1002/chem.202100528. Epub 2021 May 07.

The size of single crystals of the metal-organic framework CPO-27-Ni was incrementally increased through a series of modulated syntheses. A novel linker modulated synthesis using 2,5-dihydroxyterephthalic acid and the isomeric ligand 4,6-dihydroxyisophthalic acid yielded large single crystals of CPO-27-Ni...

Cite
Vornholt SM, Elliott CG, Rice CM, et al. Controlled Synthesis of Large Single Crystals of Metal-Organic Framework CPO-27-Ni Prepared by a Modulation Approach: In situ Single-Crystal X-ray Diffraction Studies. Chemistry. 2021;27(33):8537-8546doi: 10.1002/chem.202100528.
Vornholt, S. M., Elliott, C. G., Rice, C. M., Russell, S. E., Kerr, P. J., Rainer, D. N., Mazur, M., Warren, M. R., Wheatley, P. S., & Morris, R. E. (2021). Controlled Synthesis of Large Single Crystals of Metal-Organic Framework CPO-27-Ni Prepared by a Modulation Approach: In situ Single-Crystal X-ray Diffraction Studies. Chemistry (Weinheim an der Bergstrasse, Germany), 27(33), 8537-8546. https://doi.org/10.1002/chem.202100528
Vornholt, Simon M, et al. "Controlled Synthesis of Large Single Crystals of Metal-Organic Framework CPO-27-Ni Prepared by a Modulation Approach: In situ Single-Crystal X-ray Diffraction Studies." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 27,33 (2021): 8537-8546. doi: https://doi.org/10.1002/chem.202100528
Vornholt SM, Elliott CG, Rice CM, Russell SE, Kerr PJ, Rainer DN, Mazur M, Warren MR, Wheatley PS, Morris RE. Controlled Synthesis of Large Single Crystals of Metal-Organic Framework CPO-27-Ni Prepared by a Modulation Approach: In situ Single-Crystal X-ray Diffraction Studies. Chemistry. 2021 Jun 10;27(33):8537-8546. doi: 10.1002/chem.202100528. Epub 2021 May 07. PMID: 33783895; PMCID: PMC8251849.
Copy Download .nbib Format: NLM
Improvement of an international research experience: Year two.

Wheatley BB, Fischencih KM, Abrams LPE, Sorby SA, Mali HS, Jain AK, Donahue TLH.
UIID-AD: 4888
2017;

Six students from The Ohio State University were sent to Jaipur, India during the summer of 2015 to conduct research on the Jaipur Foot, a low cost lower limb prosthesis. As a continuation of the research conducted by the...

Cite
Wheatley BB, Fischencih KM, Abrams LPE, et al. Improvement of an international research experience: Year two. 2017;
Wheatley, B. B., Fischencih, K. M., Abrams, L. P. E., Sorby, S. A., Mali, H. S., Jain, A. K., & Donahue, T. L. H. (2017). Improvement of an international research experience: Year two. .
Wheatley, B B, et al. "Improvement of an international research experience: Year two." vol. (2017).
Wheatley BB, Fischencih KM, Abrams LPE, Sorby SA, Mali HS, Jain AK, Donahue TLH. Improvement of an international research experience: Year two. 2017; UIID-AD: 4888.
Copy Download .nbib Format: NLM
Showing 229 to 236 of 236 entries